Life Science In Sweden

A snapshot

Sweden has over 30,000 employees engaged in R&D and manufacturing and ranks 9th and 5th in Europe among 140 countries world-wide in the Global Competitiveness Index 2015-2016 ranking by World Economic Forum. Sweden also ranks 2nd per capita in the world when it comes to R&D investments. Life Science oriented universities and hospitals are to be found all over the nation, from north to south.

Life Science In Sweden

Cutting Edge Capabilities

Skype, Spotify, IKEA, Ericsson, Sobi, Elekta, Recipharm, the Nobel Prize along with a highly skilled and flexible workforce makes Sweden one of the coolest and most innovative places on the planet. Academia, healthcare providers, research infrastructure including biobanks, incubators, investors and industry are all set to accelerate innovation and international collaborations within drug development and medtech.

Life Science In Sweden

Investments

Major investments in life science capabilities and Swedish healthcare have been made during recent years and more will follow. Cutting edge research infrastructure are already largely in place. New Karolinska Solna, part of a multi-billion Euro investment in infrastructure, will be inaugurated in the autumn of 2016. AstraZeneca will build a new 225 million Euro manufacturing facility for biologics and GE Healthcare have announced a 90 million Euro investments in their protein purification production. The government, a private foundation and AstraZeneca will jointly invest in biologics and a number of other initiatives across the country are under way.

Life Science In Sweden

Life Science Organisations

The life science industry is one of Sweden’s most important sectors and a fast growing market both in Sweden and globally. Progress in the area impacts the quality of life for all of us and at the same time benefits society in terms of economic growth and cost-efficient quality healthcare. The importance of the sector is mirrored by a number of national and regional organisations supporting research, innovation and entrepreneurship.

Innovation Areas

Biotechnology

Protein research in Sweden dates back to the invention of the ultracentrifuge by The Svedberg, Nobel Laureate 1926. Since then, Sweden has held a world-class position in this field thanks to the long-standing presence of experts versed in the complexity of protein science and close interactions between health care providers and industry. Molecular and protein research is conducted in all major Swedish universities and Swedish innovations within this area are behind many solutions on the world market.

Innovation Areas

Embracing innovation in medtech

Sweden’s technology-driven environment, characterised as it is by close collaboration between academia, healthcare and industry, has produced many notable medtech innovations that have saved lives and alleviated symptoms for millions of patients globally. The pacemaker, the gamma knife and renal dialysis are just a few examples.

Innovation Areas

Proud history in drug development

Sweden has been in the forefront of drug development for decades, not least due to the heritage from Pharmacia and Astra. Today, this legacy manifests itself through the presence of a strong, life science eco-system with a pool of competent professionals all across the value chain from world-leading academic pre-clinical and clinical research to manufacturing.

Innovation Areas

Healthcare and Innovation

Sweden has made great progress in health care, from research and innovation to clinical practice and management. The Swedish healthcare system is ranked as one of the best in the world and provides an important foundation for life science innovation.

Innovation Areas

Research infrastructure

The Swedish government has made major investments in the country’s life sciences research infrastructure; the latest research bill setting new record levels. SciLifeLab and Max IV are both national resources. ESS, The European Spallation Source, which is intended to become a resource for European scientists, is under development. These resources are intended for advancing the understanding of human biology and hence leading to new innovations in the fields of prevention, diagnosis and treatment.

Opportunities

Partner with Companies

The Swedish life science industry includes 1 500 companies within pharma, biotech and medtech. Around 800 of them are engaged in research and development programs in Sweden (Vinnova Analysis 2014:13). Since Sweden is a small country with a very limited home market, companies typically plan for the global market from day one. Thus, a natural part of the business and tradition is to actively seek international collaborations, licensing and financing in order to broaden the critical mass and securing a global reach.

Opportunities

Tap into our research environments

The model of collaboration between academia, industry and the healthcare sector product development is gaining ground among global companies. Equally relevant is to use real life test environments as an innovation arena for testing technologies before launch. Swedish universities and healthcare providers welcome scientists, industry, investors and societies to come and collaborate with us on meeting the global healthcare challenges of today and tomorrow. This way, we can create value for people as well as businesses around the world and build a foundation for sustainable health.

Contact

Contact